Vascular Solutions (VASC) Cash Flow Statement

Click line-items for a historical chart and %

Net earnings	10.59M
Depreciation	3.86M
Amortization	1.21M
Stock-based compensation	3.67M
Deferred taxes, net	-1.05M
Change in allowance for doubtful accounts	-20K
Accounts receivable	-3.82M
Inventories	-2.08M
Prepaid expenses
Accounts payable	-1.72M
Accrued compensation and expenses	-833K
Amortization of deferred license fees and other deferred revenue
Net cash provided by operating activities
Purchase of property and equipment	-11.16M
Cash paid for acquisitions
Net cash used in investing activities
Repurchase of common shares	-3.53M
Proceeds from the exercise of stock options, stock warrants and sale of stock, net of expenses	2.33M
Net cash used in financing activities
Increase (decrease) in cash and cash equivalents	-2.41M
Effect of exchange rate changes on cash and cash equivalents	-19K
Cash and cash equivalents at beginning of period	41.49M
Cash and cash equivalents at end of period	39.07M
Cash paid for interest
Cash paid for taxes	2.18M

Entities mentioned with VASC

View All Entities